By Bhanvi Satija and Patrick Wingrove (Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cutting efforts and...
By Julie Steenhuysen and Tom Polansek CHICAGO (Reuters) -Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration...
(Reuters) -Emergent BioSolutions said on Wednesday that it would cut about 300 jobs across all areas of the company and shut down several manufacturing facilities as part of a restructuring...
By Brad Brooks (Reuters) -The Arizona Senate voted on Wednesday to repeal the state's 1864 ban on abortion, which could otherwise have taken effect within weeks. The repeal was passed...
By Ahmed Aboulenein and Zeba Siddiqui WASHINGTON (Reuters) - Hackers who breached UnitedHealth's tech unit in February potentially stole a third of Americans' data, the largest U.S. health insurer's CEO...
By Brendan Pierson (Reuters) -A federal judge has struck down parts of a North Carolina law restricting patients' access to the abortion pill mifepristone, which has become the subject of...
By Nandita Bose JACKSONVILLE, Florida (Reuters) -U.S. Vice President Kamala Harris sought to blame Republican candidate Donald Trump for Florida's six-week abortion ban that took effect on Wednesday, saying his...
By Dietrich Knauth and Mike Spector NEW YORK(Reuters) -Johnson & Johnson said on Wednesday it is moving forward with a $6.48 billion proposed settlement of tens of thousands of lawsuits...
By Amina Niasse NEW YORK (Reuters) - Almost all U.S. hospitals were hurt financially by the cyberattack on United Health Group’s Change Healthcare unit earlier this year, according to a...
By Tanay Dhumal (Reuters) -Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug. U.S.-listed shares...
By Bhanvi Satija and Patrick Wingrove (Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2...
By Brendan Pierson (Reuters) -The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in...
By Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza drug to treat movement disorders associated with Huntington's disease...
By Mrinalika Roy (Reuters) - The U.S. Justice Department is moving to make marijuana use a less serious federal crime with a proposal to reclassify the drug as on par...
By Jeff Mason, Pratik Jain and Sarah N. Lynch WASHINGTON (Reuters) - The U.S. Justice Department on Tuesday moved to make marijuana use a less serious federal crime, taking a...
(Adds media packaging code) (Reuters) - Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now...
By Tom Polansek CHICAGO (Reuters) -The U.S. government said on Monday it is collecting samples of ground beef at retail stores in states with outbreaks of bird flu in dairy...
By Brendan Pierson (Reuters) - Health insurance plans run by U.S. states must cover gender-affirming surgeries for transgender people, a U.S. appeals court ruled on Monday. The 8-6 opinion from...
(This April 29 story has been corrected to fix the headline and paragraph 1, and updated to clarify the breach occurred due to stolen credentials, not a Citrix vulnerability, in...
By Brendan Pierson (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices...
By Pratik Jain and Christy Santhosh (Reuters) -Annovis Bio's on Monday reported data that showed its Alzheimer's disease drug failed to show statistical significance in meeting the goals of a...
(Reuters) -The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating cervical cancer patients whose disease had progressed on or after chemotherapy, the agency said...
By Jennifer Rigby LONDON (Reuters) - Success in the fight to wipe out polio is not guaranteed, according to tech billionaire turned philanthropist Bill Gates, whose foundation has poured billions...
By Rishika Sadam and Aditya Kalra HYDERABAD (Reuters) -The U.S. Food and Drug Administration (FDA) is gathering information on products of Indian spice makers MDH and Everest after Hong Kong...
By Mariam Sunny and Vaibhav Sadhamta (Reuters) -Centene said on Friday its Medicare insurance business would face several challenges next year, taking the sheen off a strong first-quarter earnings report...
(Reuters) - Staff at CVS Health's unit Omnicare in Las Vegas voted to join the Pharmacy Guild, becoming the first location at the national pharmacy chain to join the union....
(Reuters) -The current overall public health risk posed by the H5N1 bird flu virus is low, the World Health Organization said on Friday, but urged countries to stay alert for...
By Sriparna Roy (Reuters) -The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B on Friday, the second such therapy for the rare bleeding disorder that typically...
By Jarrett Renshaw (Reuters) -The Biden administration on Friday delayed its plan to ban menthol cigarettes, a move that reflected the potential for a political backlash from Black voters in...
By Leroy Leo and Christy Santhosh (Reuters) -AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen after recent changes by U.S. pharmacy benefit managers...
